Nathalie Gault
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Nathalie Gault has a total of 195 co-authors. Here are the top co-authors by number of shared publications:
- Paul-Henri Romeo
French Institute of Health and Medical Research
6 shared publications - Federica Ferri
Laboratory on Repair and Transcription in Hematopoietic Stem Cells (LRTS/IRCM), Université Paris Cité, Inserm, CEA, 92265 Fontenay-aux-Roses, France
5 shared publications Jean-Louis Lefaix
5 shared publicationsVilma Barroca
5 shared publications- Daniel Lewandowski
CEA-INSERM UMR1274, Institut de Radiobiologie Cellulaire et Moléculaire (iRCM), Institut de Biologie François Jacob (IBFJ), Direction de la Recherche Fondamentale (DRF), CEA, Fontenay aux Roses, France
4 shared publications - Marie-Catherine Vozenin
University of Geneva
4 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by Elsevier in SSRN Electronic Journal
Low-Dose Ionizing Radiation and Haematopoiesis: A Redox-Centred Framework Integrating HSC-Intrinsic Stress and Niche Buffering
Low-dose ionizing radiation (LDIR; <100 mGy) is common in medical, environmental, and occupational settings, yet its impact on hematopoietic stem cells (HSC) remains incompletely understood. While high-dose radiation induces well-characterized DNA damage and oxidative stress, LDIR primarily triggers subtle redox perturbations affecting HSC function through intrinsic and microenvironmental mechanisms.Here, we synthesize current evidence and propose a redox-centred framework in which HSC responses to LDIR result from the interplay between intrinsic stress adaptation and bone marrow niche buffering. Ex vivo studies reveal that LDIR induces transient mitochondrial reactive oxygen species (ROS) production, coupled with endoplasmic reticulum stress and activation of adaptive pathways, including NRF2 signalling, autophagy, and the unfolded protein response. Although these mechanisms support short-term survival, they may also promote persistent ROS, organelle stress, and epigenetic remodelling, ultimately impairing long-term HSC self-renewal and function.In vivo, these defects are often mitigated by the bone marrow niche, which maintains hematopoietic homeostasis. Niche integrity determines outcome: an intact microenvironment compensates for stress-induced alterations, whereas niche disruption unmasks latent HSC defects. Radiation quality, dose rate, and chronicity, critically modulate this balance, with high-linear energy transfer radiation causing greater HSC-intrinsic damage.Elucidating how redox signalling, organelle stress and niche interactions converge to regulate HSC fate will be essential for improving radiological risk assessment and hematopoietic protection.
- 7 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessLow-Dose Ionizing Radiation and Haematopoiesis: A Redox-Centred Framework Integrating HSC-Intrinsic Stress and Niche Buffering
Low-dose ionizing radiation (LDIR; <100 mGy) is common in medical, environmental, and occupational settings, yet its impact on hematopoietic stem cells (HSC) remains incompletely understood. While high-dose radiation induces well-characterized DNA damage and oxidative stress, LDIR primarily triggers subtle redox perturbations affecting HSC function through intrinsic and microenvironmental mechanisms.Here, we synthesize current evidence and propose a redox-centred framework in which HSC responses to LDIR result from the interplay between intrinsic stress adaptation and bone marrow niche buffering. Ex vivo studies reveal that LDIR induces transient mitochondrial reactive oxygen species (ROS) production, coupled with endoplasmic reticulum stress and activation of adaptive pathways, including NRF2 signalling, autophagy, and the unfolded protein response. Although these mechanisms support short-term survival, they may also promote persistent ROS, organelle stress, and epigenetic remodelling, ultimately impairing long-term HSC self-renewal and function.In vivo, these defects are often mitigated by the bone marrow niche, which maintains hematopoietic homeostasis. Niche integrity determines outcome: an intact microenvironment compensates for stress-induced alterations, whereas niche disruption unmasks latent HSC defects. Radiation quality, dose rate, and chronicity, critically modulate this balance, with high-linear energy transfer radiation causing greater HSC-intrinsic damage.Elucidating how redox signalling, organelle stress and niche interactions converge to regulate HSC fate will be essential for improving radiological risk assessment and hematopoietic protection.
- 25 September 2026
- Published by American Society of Hematology in Blood
Characterization of disease-initiating hematopoietic stem cells in calreticulin-mutated myeloproliferative neoplasms
Myeloproliferative neoplasms (MPNs) arise following the acquisition of a mutation in a hematopoietic stem cell (HSC) that causes oncogenic cytokine receptor signaling. Mutations in the calreticulin (CALR) gene are the second most common key driver mutations in MPNs, yet the identity of the disease-initiating HSCs and the mechanisms underlying their clonal expansion remain elusive. Knock-in mice bearing CALRdel52 and CALRins5 mutations recapitulate disease phenotypes, with a greater HSC amplification in CALRdel52 mice. Here, we crossed these strains with transgenic reporter mice expressing GFP under the control of the Von willebrand factor (Vwf) promoter, enabling discrimination between different HSC subsets. We show that CALR-mutated MPNs are mainly initiated from the expansion of platelet-biased, Vwf-positive HSCs, without substantially altering their lineage bias. Notably, the selective amplification of Vwf-positive CALRdel52 compared to CALRins5 HSCs is associated with increased signaling of the thrombopoietin receptor MPL and activation of the integrated stress response as evidenced by eIF2a phosphorylation downstream of PERK kinase triggered by endoplasmic reticulum stress. This pathway is also transcriptionally upregulated in CALRdel52-like compared with CALRins5-like patient hematopoietic stem and progenitor cells (HSPCs), as supported by reanalysis of a previous dataset, and is associated with increased phosphorylation of eIF2a. Pharmacological inhibition of PERK markedly reduces the proliferation of mouse CALRdel52 HSCs and impairs the megakaryocytic differentiation of CALRdel52-like HSPCs from patients while sparing cells from healthy donors. These findings identify the PERK/eIF2a pathway as a mechanistic vulnerability in the MPN cell-of-origin and offer a rationale for exploring new treatment approaches.
- 25 September 2026
- Published by American Society of Hematology in Blood
Characterization of disease-initiating hematopoietic stem cells in calreticulin-mutated myeloproliferative neoplasms
Myeloproliferative neoplasms (MPNs) arise following the acquisition of a mutation in a hematopoietic stem cell (HSC) that causes oncogenic cytokine receptor signaling. Mutations in the calreticulin (CALR) gene are the second most common key driver mutations in MPNs, yet the identity of the disease-initiating HSCs and the mechanisms underlying their clonal expansion remain elusive. Knock-in mice bearing CALRdel52 and CALRins5 mutations recapitulate disease phenotypes, with a greater HSC amplification in CALRdel52 mice. Here, we crossed these strains with transgenic reporter mice expressing GFP under the control of the Von willebrand factor (Vwf) promoter, enabling discrimination between different HSC subsets. We show that CALR-mutated MPNs are mainly initiated from the expansion of platelet-biased, Vwf-positive HSCs, without substantially altering their lineage bias. Notably, the selective amplification of Vwf-positive CALRdel52 compared to CALRins5 HSCs is associated with increased signaling of the thrombopoietin receptor MPL and activation of the integrated stress response as evidenced by eIF2a phosphorylation downstream of PERK kinase triggered by endoplasmic reticulum stress. This pathway is also transcriptionally upregulated in CALRdel52-like compared with CALRins5-like patient hematopoietic stem and progenitor cells (HSPCs), as supported by reanalysis of a previous dataset, and is associated with increased phosphorylation of eIF2a. Pharmacological inhibition of PERK markedly reduces the proliferation of mouse CALRdel52 HSCs and impairs the megakaryocytic differentiation of CALRdel52-like HSPCs from patients while sparing cells from healthy donors. These findings identify the PERK/eIF2a pathway as a mechanistic vulnerability in the MPN cell-of-origin and offer a rationale for exploring new treatment approaches.
- Open Access
- 11 August 2023
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 14 (1) , 1-22
Fetal Muse-based therapy prevents lethal radio-induced gastrointestinal syndrome by intestinal regeneration
Background: Human multilineage-differentiating stress enduring (Muse) cells are nontumorigenic endogenous pluripotent-like stem cells that can be easily obtained from various adult or fetal tissues. Regenerative effects of Muse cells have been shown in some disease models. Muse cells specifically home in damaged tissues where they exert pleiotropic effects. Exposition of the small intestine to high doses of irradiation (IR) delivered after radiotherapy or nuclear accident results in a lethal gastrointestinal syndrome (GIS) characterized by acute loss of intestinal stem cells, impaired epithelial regeneration and subsequent loss of the mucosal barrier resulting in sepsis and death. To date, there is no effective medical treatment for GIS. Here, we investigate whether Muse cells can prevent lethal GIS and study how they act on intestinal stem cell microenvironment to promote intestinal regeneration. Methods: Human Muse cells from Wharton’s jelly matrix of umbilical cord (WJ-Muse) were sorted by flow cytometry using the SSEA-3 marker, characterized and compared to bone-marrow derived Muse cells (BM-Muse). Under gas anesthesia, GIS mice were treated or not through an intravenous retro-orbital injection of 50,000 WJ-Muse, freshly isolated or cryopreserved, shortly after an 18 Gy-abdominal IR. No immunosuppressant was delivered to the mice. Mice were euthanized either 24 h post-IR to assess early small intestine tissue response, or 7 days post-IR to assess any regenerative response. Mouse survival, histological stainings, apoptosis and cell proliferation were studied and measurement of cytokines, recruitment of immune cells and barrier functional assay were performed. Results: Injection of WJ-Muse shortly after abdominal IR highly improved mouse survival as a result of a rapid regeneration of intestinal epithelium with the rescue of the impaired epithelial barrier. In small intestine of Muse-treated mice, an early enhanced secretion of IL-6 and MCP-1 cytokines was observed associated with (1) recruitment of monocytes/M2-like macrophages and (2) proliferation of Paneth cells through activation of the IL-6/Stat3 pathway. Conclusion: Our findings indicate that a single injection of a small quantity of WJ-Muse may be a new and easy therapeutic strategy for treating lethal GIS.
- 11 August 2023
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 14 (1) , 1-22
Open AccessFetal Muse-based therapy prevents lethal radio-induced gastrointestinal syndrome by intestinal regeneration
Background: Human multilineage-differentiating stress enduring (Muse) cells are nontumorigenic endogenous pluripotent-like stem cells that can be easily obtained from various adult or fetal tissues. Regenerative effects of Muse cells have been shown in some disease models. Muse cells specifically home in damaged tissues where they exert pleiotropic effects. Exposition of the small intestine to high doses of irradiation (IR) delivered after radiotherapy or nuclear accident results in a lethal gastrointestinal syndrome (GIS) characterized by acute loss of intestinal stem cells, impaired epithelial regeneration and subsequent loss of the mucosal barrier resulting in sepsis and death. To date, there is no effective medical treatment for GIS. Here, we investigate whether Muse cells can prevent lethal GIS and study how they act on intestinal stem cell microenvironment to promote intestinal regeneration. Methods: Human Muse cells from Wharton’s jelly matrix of umbilical cord (WJ-Muse) were sorted by flow cytometry using the SSEA-3 marker, characterized and compared to bone-marrow derived Muse cells (BM-Muse). Under gas anesthesia, GIS mice were treated or not through an intravenous retro-orbital injection of 50,000 WJ-Muse, freshly isolated or cryopreserved, shortly after an 18 Gy-abdominal IR. No immunosuppressant was delivered to the mice. Mice were euthanized either 24 h post-IR to assess early small intestine tissue response, or 7 days post-IR to assess any regenerative response. Mouse survival, histological stainings, apoptosis and cell proliferation were studied and measurement of cytokines, recruitment of immune cells and barrier functional assay were performed. Results: Injection of WJ-Muse shortly after abdominal IR highly improved mouse survival as a result of a rapid regeneration of intestinal epithelium with the rescue of the impaired epithelial barrier. In small intestine of Muse-treated mice, an early enhanced secretion of IL-6 and MCP-1 cytokines was observed associated with (1) recruitment of monocytes/M2-like macrophages and (2) proliferation of Paneth cells through activation of the IL-6/Stat3 pathway. Conclusion: Our findings indicate that a single injection of a small quantity of WJ-Muse may be a new and easy therapeutic strategy for treating lethal GIS.
- Open Access
- 20 March 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (12) , eaay3704
Phagocytosis of Wnt inhibitor SFRP4 by late wound macrophages drives chronic Wnt activity for fibrotic skin healing
Macrophages, renowned for clearance of debris and bacteria in the wound, can also uptake signaling inhibitors to promote fibrosis.
- 20 March 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (12) , eaay3704
Open AccessPhagocytosis of Wnt inhibitor SFRP4 by late wound macrophages drives chronic Wnt activity for fibrotic skin healing
Macrophages, renowned for clearance of debris and bacteria in the wound, can also uptake signaling inhibitors to promote fibrosis.
- Open Access
- 1 August 2019
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 105 (5) , 1216-1222
Prion protein deficiency impairs hematopoietic stem cell determination and sensitizes myeloid progenitors to irradiation
Highly conserved among species and expressed in various types of cells, numerous roles have been attributed to the cellular prion protein (PrPC). In hematopoiesis, PrPC regulates hematopoietic stem cell self-renewal but the mechanisms involved in this regulation are unknown. Here we show that PrPC regulates hematopoietic stem cell number during aging and their determination towards myeloid progenitors. Furthermore, PrPC protects myeloid progenitors against the cytotoxic effects of total body irradiation. This radioprotective effect was associated with increased cellular prion mRNA level and with stimulation of the DNA repair activity of the Apurinic/pyrimidinic endonuclease 1, a key enzyme of the base excision repair pathway. Altogether, these results show a previously unappreciated role of PrPC in adult hematopoiesis, and indicate that PrPC-mediated stimulation of BER activity might protect hematopoietic progenitors from the cytotoxic effects of total body irradiation.
- 1 August 2019
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 105 (5) , 1216-1222
Open AccessPrion protein deficiency impairs hematopoietic stem cell determination and sensitizes myeloid progenitors to irradiation
Highly conserved among species and expressed in various types of cells, numerous roles have been attributed to the cellular prion protein (PrPC). In hematopoiesis, PrPC regulates hematopoietic stem cell self-renewal but the mechanisms involved in this regulation are unknown. Here we show that PrPC regulates hematopoietic stem cell number during aging and their determination towards myeloid progenitors. Furthermore, PrPC protects myeloid progenitors against the cytotoxic effects of total body irradiation. This radioprotective effect was associated with increased cellular prion mRNA level and with stimulation of the DNA repair activity of the Apurinic/pyrimidinic endonuclease 1, a key enzyme of the base excision repair pathway. Altogether, these results show a previously unappreciated role of PrPC in adult hematopoiesis, and indicate that PrPC-mediated stimulation of BER activity might protect hematopoietic progenitors from the cytotoxic effects of total body irradiation.
- 20 February 2019
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 95 (7) , 892-899
Hematopoietic stem and progenitor cell responses to low radiation doses – implications for leukemia risk
Studies of the responses of hematopoietic stem and progenitor cells (HSPCs) to low doses of ionizing radiation formed an important aspect of the RISK-IR project ( www.risk-ir.eu ). A brief overview of these studies is presented here. The findings confirm the sensitivity of HSPCs to radiation even at low doses, and illustrate the substantial impact that differentiation state has upon cell sensitivity. The work provides mechanistic support for epidemiological findings of leukemia risk at dose levels used in diagnostic CT imaging, and further suggests that low-dose irradiation may facilitate bone marrow transplantation, a finding that could lead to refinements in clinical practice.
- 20 February 2019
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 95 (7) , 892-899
Hematopoietic stem and progenitor cell responses to low radiation doses – implications for leukemia risk
Studies of the responses of hematopoietic stem and progenitor cells (HSPCs) to low doses of ionizing radiation formed an important aspect of the RISK-IR project ( www.risk-ir.eu ). A brief overview of these studies is presented here. The findings confirm the sensitivity of HSPCs to radiation even at low doses, and illustrate the substantial impact that differentiation state has upon cell sensitivity. The work provides mechanistic support for epidemiological findings of leukemia risk at dose levels used in diagnostic CT imaging, and further suggests that low-dose irradiation may facilitate bone marrow transplantation, a finding that could lead to refinements in clinical practice.
- Open Access
- 1 September 2017
- Published by Elsevier in Cell Reports
- Vol. 20 (13) , 3199-3211
Low-Dose Irradiation Promotes Persistent Oxidative Stress and Decreases Self-Renewal in Hematopoietic Stem Cells
- 1 September 2017
- Published by Elsevier in Cell Reports
- Vol. 20 (13) , 3199-3211
Open AccessLow-Dose Irradiation Promotes Persistent Oxidative Stress and Decreases Self-Renewal in Hematopoietic Stem Cells
- Open Access
- 10 December 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (3) , 5111-5122
Macrophage production and activation are dependent on TRIM33
Macrophage production and activation are dependent on TRIM33 Macrophage production and activation are dependent on TRIM33
- 10 December 2016
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (3) , 5111-5122
Open AccessMacrophage production and activation are dependent on TRIM33
Macrophage production and activation are dependent on TRIM33 Macrophage production and activation are dependent on TRIM33
- 1 April 2011
- Published by Elsevier in Cell Stem Cell
- Vol. 8 (4) , 412-425
Adult Hematopoiesis is Regulated by TIF1γ, a Repressor of TAL1 and PU.1 Transcriptional Activity
- 1 April 2011
- Published by Elsevier in Cell Stem Cell
- Vol. 8 (4) , 412-425
Adult Hematopoiesis is Regulated by TIF1γ, a Repressor of TAL1 and PU.1 Transcriptional Activity